Cohance Lifesciences Limited (NSE:COHANCE)

Cohance Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	383,447	293,004	172,366	120,256	157,436	126,468
Market Cap Growth	69.99%	69.99%	43.33%	-23.61%	24.49%	394.20%
Enterprise Value	384,874	287,341	165,176	117,048	156,449	127,128
Last Close Price	1002.30	1151.00	677.10	472.40	608.53	484.99
PE Ratio	95.91	109.38	57.40	29.24	34.69	34.90
Forward PE	59.50	80.68	44.40	26.23	30.48	29.75
PS Ratio	32.02	24.47	16.40	8.97	11.93	12.53
PB Ratio	20.83	15.92	8.40	6.93	10.31	10.71
P/TBV Ratio	39.22	29.97	8.67	7.19	10.32	10.73
P/FCF Ratio	289.50	221.22	56.20	70.21	61.79	46.55
P/OCF Ratio	133.07	101.68	48.08	26.30	47.71	33.06
EV/Sales Ratio	32.14	23.99	15.71	8.73	11.85	12.59
EV/EBITDA Ratio	102.58	76.58	40.65	20.44	27.00	28.85
EV/EBIT Ratio	129.28	96.52	46.59	22.25	28.89	31.02
EV/FCF Ratio	290.58	216.94	53.86	68.34	61.40	46.79
Debt / Equity Ratio	0.15	0.15	0.03	0.04	0.06	0.12
Debt / EBITDA Ratio	0.74	0.74	0.16	0.12	0.17	0.32
Debt / FCF Ratio	2.11	2.11	0.21	0.41	0.38	0.53
Asset Turnover	0.45	0.45	0.50	0.71	0.80	0.76
Inventory Turnover	1.53	1.53	1.60	1.87	2.24	2.19
Quick Ratio	1.57	1.57	9.46	4.17	3.85	1.56
Current Ratio	2.43	2.43	11.82	6.37	5.36	2.57
Return on Equity (ROE)	13.61%	13.61%	15.86%	25.21%	33.52%	35.78%
Return on Assets (ROA)	7.04%	7.04%	10.50%	17.33%	20.49%	19.35%
Return on Capital (ROIC)	8.79%	8.79%	11.30%	19.18%	22.96%	21.76%
Return on Capital Employed (ROCE)	11.20%	11.20%	16.50%	29.10%	33.40%	32.70%
Earnings Yield	0.70%	0.91%	1.74%	3.42%	2.88%	2.86%
FCF Yield	0.35%	0.45%	1.78%	1.42%	1.62%	2.15%
Dividend Yield	-	-	-	-	0.33%	0.41%
Payout Ratio	-	-	-	49.52%	11.22%	7.03%
Buyback Yield / Dilution	-0.69%	-0.69%	-	-	-	0.00%
Total Shareholder Return	-	-0.69%	-	-	0.33%	0.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.